vs
Aclarion, Inc.（ACON）与Natera, Inc.（NTRA）财务数据对比。点击上方公司名可切换其他公司
Natera, Inc.的季度营收约是Aclarion, Inc.的36015.8倍（$665.5M vs $18.5K）。Natera, Inc.净利率更高（7.1% vs -10223.7%，领先10230.8%）。Aclarion, Inc.同比增速更快（80.6% vs 39.8%）。过去两年Aclarion, Inc.的营收复合增速更高（35.2% vs 34.5%）
Aclarion, Inc.是一家专注于慢性下背痛诊疗的医疗科技企业，核心产品基于专利磁共振波谱技术，可精准识别患者的疼痛性椎间盘，服务美国市场的医疗机构与患者，业务覆盖慢性疼痛管理、脊柱护理两大核心领域。
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
ACON vs NTRA — 直观对比
营收规模更大
NTRA
是对方的36015.8倍
$18.5K
营收增速更快
ACON
高出40.8%
39.8%
净利率更高
NTRA
高出10230.8%
-10223.7%
两年增速更快
ACON
近两年复合增速
34.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.5K | $665.5M |
| 净利润 | $-1.9M | $47.3M |
| 毛利率 | 9.7% | — |
| 营业利润率 | -10785.8% | -3.4% |
| 净利率 | -10223.7% | 7.1% |
| 营收同比 | 80.6% | 39.8% |
| 净利润同比 | 5.0% | 187.9% |
| 每股收益（稀释后） | $1.39 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACONNTRA
| Q4 25 | $18.5K | $665.5M | ||
| Q3 25 | $18.9K | $592.2M | ||
| Q2 25 | $19.3K | $546.6M | ||
| Q1 25 | $19.0K | $501.8M | ||
| Q4 24 | $10.2K | $476.1M | ||
| Q3 24 | $14.4K | $439.8M | ||
| Q2 24 | $11.0K | $413.4M | ||
| Q1 24 | $10.1K | $367.7M |
净利润ACONNTRA
| Q4 25 | $-1.9M | $47.3M | ||
| Q3 25 | $-1.7M | $-87.5M | ||
| Q2 25 | $-1.6M | $-100.9M | ||
| Q1 25 | $-2.0M | $-66.9M | ||
| Q4 24 | $-2.0M | $-53.8M | ||
| Q3 24 | $-1.4M | $-31.6M | ||
| Q2 24 | $-1.2M | $-37.5M | ||
| Q1 24 | $-2.4M | $-67.6M |
毛利率ACONNTRA
| Q4 25 | 9.7% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | -23.6% | — | ||
| Q4 24 | -100.9% | — | ||
| Q3 24 | -48.1% | — | ||
| Q2 24 | -112.3% | — | ||
| Q1 24 | -92.6% | — |
营业利润率ACONNTRA
| Q4 25 | -10785.8% | -3.4% | ||
| Q3 25 | -9666.2% | -16.5% | ||
| Q2 25 | -8988.6% | -20.2% | ||
| Q1 25 | -7856.0% | -15.8% | ||
| Q4 24 | -17652.7% | -13.6% | ||
| Q3 24 | -8995.3% | -8.9% | ||
| Q2 24 | -10350.6% | -10.6% | ||
| Q1 24 | -12609.3% | -20.2% |
净利率ACONNTRA
| Q4 25 | -10223.7% | 7.1% | ||
| Q3 25 | -9008.0% | -14.8% | ||
| Q2 25 | -8285.9% | -18.5% | ||
| Q1 25 | -10728.4% | -13.3% | ||
| Q4 24 | -19444.6% | -11.3% | ||
| Q3 24 | -9482.7% | -7.2% | ||
| Q2 24 | -11285.0% | -9.1% | ||
| Q1 24 | -23720.6% | -18.4% |
每股收益（稀释后）ACONNTRA
| Q4 25 | $1.39 | $0.36 | ||
| Q3 25 | $-2.93 | $-0.64 | ||
| Q2 25 | $-2.75 | $-0.74 | ||
| Q1 25 | $-9.32 | $-0.50 | ||
| Q4 24 | $-809.36 | $-0.41 | ||
| Q3 24 | $-1321.49 | $-0.26 | ||
| Q2 24 | $-1362.83 | $-0.30 | ||
| Q1 24 | $-3985.22 | $-0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.8M | $1.7B |
| 总资产 | $13.7M | $2.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACONNTRA
| Q4 25 | $12.0M | — | ||
| Q3 25 | $11.3M | $1.0M | ||
| Q2 25 | $12.8M | $16.0M | ||
| Q1 25 | $14.8M | $17.8M | ||
| Q4 24 | $453.7K | $22.7M | ||
| Q3 24 | $1.3M | $29.5M | ||
| Q2 24 | $1.2M | $90.3M | ||
| Q1 24 | $2.1M | $69.1M |
股东权益ACONNTRA
| Q4 25 | $12.8M | $1.7B | ||
| Q3 25 | $12.5M | $1.3B | ||
| Q2 25 | $14.2M | $1.2B | ||
| Q1 25 | $15.8M | $1.2B | ||
| Q4 24 | $970.1K | $1.2B | ||
| Q3 24 | $2.5M | $878.5M | ||
| Q2 24 | $1.6M | $836.5M | ||
| Q1 24 | $2.5M | $794.1M |
总资产ACONNTRA
| Q4 25 | $13.7M | $2.4B | ||
| Q3 25 | $13.2M | $1.8B | ||
| Q2 25 | $14.8M | $1.8B | ||
| Q1 25 | $16.5M | $1.7B | ||
| Q4 24 | $2.1M | $1.7B | ||
| Q3 24 | $3.2M | $1.6B | ||
| Q2 24 | $3.1M | $1.5B | ||
| Q1 24 | $3.7M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $73.9M |
| 自由现金流经营现金流 - 资本支出 | — | $37.8M |
| 自由现金流率自由现金流/营收 | — | 5.7% |
| 资本支出强度资本支出/营收 | — | 5.4% |
| 现金转化率经营现金流/净利润 | — | 1.56× |
| 过去12个月自由现金流最近4个季度 | — | $109.1M |
8季度趋势，按日历期对齐
经营现金流ACONNTRA
| Q4 25 | $-1.6M | $73.9M | ||
| Q3 25 | $-1.2M | $59.4M | ||
| Q2 25 | $-1.9M | $37.6M | ||
| Q1 25 | $-2.5M | $44.5M | ||
| Q4 24 | $-922.9K | $52.9M | ||
| Q3 24 | $-1.1M | $51.8M | ||
| Q2 24 | $-1.1M | $4.0M | ||
| Q1 24 | $-2.2M | $27.0M |
自由现金流ACONNTRA
| Q4 25 | — | $37.8M | ||
| Q3 25 | $-1.2M | $37.0M | ||
| Q2 25 | — | $11.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | — | $34.8M | ||
| Q3 24 | — | $35.5M | ||
| Q2 24 | — | $-7.7M | ||
| Q1 24 | — | $6.7M |
自由现金流率ACONNTRA
| Q4 25 | — | 5.7% | ||
| Q3 25 | -6164.6% | 6.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | -1.9% | ||
| Q1 24 | — | 1.8% |
资本支出强度ACONNTRA
| Q4 25 | — | 5.4% | ||
| Q3 25 | 38.6% | 3.8% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | 0.0% | 3.7% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 5.5% |
现金转化率ACONNTRA
| Q4 25 | — | 1.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
